|Articles|April 15, 2002

BioPharm International

  • BioPharm International-09-01-2002
  • Volume 15
  • Issue 9

Virus Inactivation in the 1990s ? and into the 21st Century Part 3a, Plasma and Plasma Products (Heat and Solvent/Detergent Treatments)

Author(s)Gail Sofer

by Gail Sofer, BioReliance Plasma products have been associated with high levels of risk from viral contamination; therefore, most viral inactivation methods described in the literature during the past ten years have addressed plasma and plasma products. Plasma is the largest group to cover, and Part 3 takes two articles in our series to describe the many methods published. This article covers heat and solvent/detergent inactivation treatments for plasma.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.